Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy

Journal of Controlled Release

Volumn 43, Issue 2-3, 1997, Pages 261-272

  Chen, L ^a   Apte, R N ^a   Cohen, S ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Biodegradable microspheres; Controlled release; Interleukin 1 ; Protein stability; Tumor immunotherapy

Indexed keywords

CYTOKINE; MICROSPHERE; POLYGLACTIN; POLYMER; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; DRUG ACTIVITY; DRUG DEGRADATION; DRUG RELEASE; ENCAPSULATION; FIBROSARCOMA; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN STABILITY; SUSTAINED RELEASE PREPARATION;

EID: 0031060125     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01496-4     Document Type: Article

References (28)

1. M.J. Berendt and R.J. North, T-cell-mediated suppression of anti tumor immunity. An explanation for progressive growth of an immunogenic tumor. J. Exp. Med. 151 (1980) 69–80.
2. R.N. Apte, A. Douvdevani, M. Zoller, R.M. White, T. Dvorkin, N. Shimoni, M. Huleihel, E. Fima, M. Hacham, E. Voronov and S. Segal, Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumor cells: mechanisms of tumour rejection and immunotherapeutical implications. Folia Biol. (Praha) 40 (1994) 1–18.
3. J.W. Smith, D.L. Longo, W.G. Alvord, J.E. Janic, W.H. Sharfman, B.L. Gause, B.D. Curti, S.P. Creekmore, J.T. Holmlund, R.G. Fenton, M. Szoni, L.L. Miller, M. Shimizu, J.J. Oppenheim, S.J. Fiem, J.C. Hursey, G.C. Powers and W. Urba, The effects of treatment with interleukin-1 α on platelet recovery after high-dose carboplatin. N. Engl. J. Med. 328 (1993) 756–761.
4. A. Douvdevani, M. Huleihel, M. Zoller, S. Segal and R.N. Apte, Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer. Int. J. Cancer 51 (1992) 822–830.
5. S.A. Rosenberg, M.T. Lotze, and L.M. Muul, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med. 316 (1987) 889–897.
6. D. Engelstein, J. Shmueli, O. Kessler, E. Mukamel, B. Nussbaum, H. Hadar, Z. Ossimi and C. Servadio, Immunotherapy for metastatic renal cell carcinoma: treatment with PLAK cells and low-dose interleukin-2. Harefuah 122 (1992) 72–76.
7. S. Nakamura, K. Nakata, S. Kashimoto, H. Yoshida and M. Yamada, Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors. Jpn. J Cancer Res. 77 (1986) 767–773.
8. D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers. In: M. Chasin and R. Langer (Eds.) Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, NY, 1990, pp. 1–42.
9. 3H]propionate), J Cell. Sci. (1980) 32–45.
10. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713–720.
11. C. Confalonieri, G. Cristina and M. Farina, The use of a new laser particle sizer and shape analyser to detect and evaluate gelatinous microparticles suspended in reconstituted anthracycline infusion solutions, J Pharm. Biomed. Anal. 9 (1991) 1–8.
12. J.A. Symons, E.M. Dickens, F. Di Giovine, and D.W. Duff, Measurement of IL-1 activity. In: M.J. Clemens, A.G. Morris, and A.J.H. Gearing (Eds.) Lymphokine and Interferons, A Practical Approach, Washington, 1987, pp. 269–289.
13. K. Nakano, K. Okugawa, H. Hayashi, S. Abe, Y. Sohmura and T. Tsuboi, Establishment of dye-uptake method (A375 Assay) for quantitative measurement of IL-1: correlation with LAF assay. Dev. Biol. Standard 69 (1988) 93–101.
14. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65 (1983) 55–63.
15. M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber and R. Langer, Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res. 10 (1993) 945–953.
16. Y. Tabata and Y. Ikada, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials 9 (1988) 356–362.
17. M. Vert, J. Mauduit and S. Li, Biodegradation of PLA/GA polymers: increasing complexity, Biomaterials 15 (1994) 1209–1213.
18. A.M. Reed and D.K. Gilding, Biodegradable polymers for use in surgery- poly(glycolic)/poly(lactic acid) homo- and co-polymers. 2. In-vitro degradation. Polymer 22 (1981) 494–498.
19. H.T. Wang, H. Palmer, R.J. Linhardt, D.R. Flanagan and E. Schmitt, Degradation of poly(ester) microspheres. Biomaterials 11 (1990) 679–685.
20. S. Li, H. Garreau, and M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly-(alpha-hydroxy acids) in aqueous media, part II: degradation of lactide-glycolide copolymers PLA37.5GA25 and LA75GA25. J. Mater. Sci. Mater. Med. 1 (1990) 131–139.
21. T.G. Park, Degradation of poly(lactic-co-glycolic acid) microsphere: effect of copolymer composition, Biomaterials 16 (1995) 1123–1130.
22. C.A. Dinarello, Interleukin-1 and interleukin-1 antagonism, Blood 77 (1991) 1627–1652.
23. T.G. Park, W. Lu and G. Crotts, Importance of in-vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly( d , l -lactic acid-co-glycolic acid) microspheres. J. Control. Rel. 33 (1995) 211–222.
24. M.C. Manning, A. Patel and A. Borchardt, Stability of protein pharmaceuticals. Pharm. Res. 6 (1989) 903–918.
25. U. Gubler, A.O. Chua, A.S. Stern, C.P. Hellmann, M.P. Vitek, T.M. Dechiara, W.R. Benjamin, K.J. Collier, M. Dukovich, P.C. Familetti, C. Fiedler-Nagy, J. Jenson, K. Kaffka, P.L. Kilian, D. Stremlo, B.H. Wittreich, D. Woehle and S.B. Mizel, Recombinant human interleukin-1 α : purification and biological characterization. J. Immunol. 136 (1986) 2492–2497.
26. D. Volkin, and A.M. Klibanov, Minimizing protein inactivation. In: Creighton (Ed.) Protein Function: A Practical Approach, Oxford University Press, Oxford, 1989, pp. 1–100
27. M. Zoller, A. Douvdevani, S. Segal and R.N. Apte, Interleukin-1 production by tumorigenic fibroblasts. II. Influence of antigen presentation and T cell-mediated anti-tumor response. Int. J. Cancer 50 (1992) 450–457.
28. S. Cohen, L. Chen and R.N. Apte, Controlled release of peptides and proteins from biodegradable polyester microspheres: an approach for treating infectious diseases and malignancies. React. Polym. 25 (1995) 177–187.